regn-846
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2010 (NCT01209793)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetOTHER
Unknown
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109648 ↗
Also known as
- regn846
- regn-846
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01605708 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2012 | Regeneron |
| NCT01209793 | Phase 1 | Nov 1, 2010 | Regeneron, Sanofi |
Showing 2 of 2 trials
Page 1 / 1